| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 3,028,000 | 3,340,000 | 3,349,000 | 3,507,000 | | Cost of Revenue | 1,886,000 | 2,143,000 | 2,109,000 | 2,157,000 | | | Gross Profit | 1,142,000 | 1,197,000 | 1,240,000 | 1,350,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 864,000 | 1,017,000 | 1,041,000 | 967,000 | | Non Recurring | 16,000 | 147,000 | (154,000) | 889,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 262,000 | 33,000 | 353,000 | (506,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,000 | 6,000 | 21,000 | 21,000 | | Earnings Before Interest And Taxes | 273,000 | 39,000 | 374,000 | (485,000) | | Interest Expense | 45,000 | 41,000 | 46,000 | 44,000 | | Income Before Tax | 228,000 | (2,000) | 328,000 | (529,000) | | Income Tax Expense | 63,000 | 15,000 | 98,000 | 128,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 165,000 | (17,000) | 230,000 | (657,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (15,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 165,000 | (17,000) | 230,000 | (672,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $165,000 | ($17,000) | $230,000 | ($672,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
